Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9
Published February 20, 2013 · Recall initiated: November 20, 2012
Summary
FDA records drug Class II recall D-160-2013, published February 20, 2013 and initiated November 20, 2012. Recalling firm: Upsher Smith Laboratories, Inc.; Status: Terminated; Reported quantity: 60 bottles; Lot: Lot #308198, Expiration Date is 03/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Test Requirements
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Upsher Smith Laboratories, Inc.
- Distributor
- FL, NJ.
- Lot
- Lot #308198, Expiration Date is 03/2014
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs,April 30, 2014
- FDAPropofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 200 mg/20 mL (10 mg/mL),February 20, 2013
- FDA12-Hour Sinus (oxymetazoline hydrochloride) Nasal Spray, 0.05%, 1 FL OZ (30 mL), labeled as a) 12 HOUR SINUSFebruary 20, 2013
- FDALac-Hydrin (ammonium lactate) Lotion, 12%, packaged in 400 g bottles, Rx only, Ranbaxy, Jacksonville, FL 32257February 20, 2013
- FDACustom Breast Biopsy Tray w/Sodium Chloride, Catalog # B9-15263A, packaged in bags, 1 tray/bag, 20 bags/case.February 13, 2013
- FDADivalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle,January 23, 2013
Questions about this recall
Was Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9 recalled?
Yes. FDA published recall D-160-2013 on February 20, 2013. Reported hazard: Failed Dissolution Test Requirements
What should I do if I have this product?
Voluntary: Firm initiated · Telephone